Teens and Steroids: A Dangerous Combo

Image Español The abuse of anabolic steroids can cause both temporary and permanent injury to anyone using them. Teenagers, whose bodies are still developing, are at heightened risk. An alarming number of them are trying steroids in hopes of improving their athletic prowess or their appearance. Ali Mohamadi, M.D., a medical officer in the Food…

Los productos inyectables para aclarar y blanquear la piel pueden ser peligrosos

Image English Los consumidores deben tener cuidado con los productos para aclarar o blanquear su cutis. Estos productos, que incluyen tanto para productos para aclarar la piel inyectable como productos blanqueadores de piel, son potencialmente peligrosos e ineficaces, y pueden contener ingredientes nocivos o contaminantes desconocidos. Los productos para blanquear la piel inyectables se comercializan…

Generic Drugs Undergo Rigorous FDA Scrutiny

An FDA scientist in the agency’s Division of Product Quality Research evaluates beads used for coating a controlled-release product. For this and other photos of FDA’s generic drug research, go to Flickr. Español Perhaps you’ve had this experience: You go to your local pharmacy to fill a prescription from your doctor, and the pharmacist confirms…

2022 Medical Device Recalls

The list below contains recalls that were issued in 2022. 2022 Medical Device Recalls Content current as of: 01/03/2022 Regulated Product(s) Article source: http://www.fda.gov/medical-devices/medical-device-recalls/2022-medical-device-recalls

Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Clobetasol Propionate Ointment USP, 0.05%, 60 g Tubes, Lot AC13786 Due to Microbial Contamination

Summary Company Announcement Date: December 27, 2021 FDA Publish Date: December 30, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Presence of Ralstonia pickettii bacteria Company Name: Taro Pharmaceuticals USA, Inc. Brand Name: Brand Name(s) Product Description: Product Description Clobetasol Propionate Company Announcement FOR IMMEDIATE RELEASE – Hawthorne, NY, December 27, 2021 ─…

Padagis Issues Voluntary Nationwide Recall for Nitroglycerin Lingual Spray Due to a Possible Defective Delivery System

Summary Company Announcement Date: December 27, 2021 FDA Publish Date: December 27, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Unit may not properly dispense medication. Company Name: Padagis Brand Name: Brand Name(s) Product Description: Product Description Nitroglycerin Lingual Spray Company Announcement FOR IMMEDIATE RELEASE – Allegan, Michigan – December 27, 2021 –…

Lock it Up: Medicine Safety in Your Home

[embedded content] Every year thousands of children are hospitalized—and some die—after taking medicine not meant for them. Teens share stolen prescription drugs at “pharm parties” and toddlers are tempted by colorful pills that look like candy. In this Consumer Update video, FDA pharmacist Connie Jung explains how you can prevent harm by locking your medicine…

Getinge’s Maquet/Datascope IABP Devices: Update on Device Failure – Letter to Health Care Providers

December 22, 2021 The U.S. Food and Drug Administration (FDA) is providing updated information about our ongoing evaluation and monitoring of device failures associated with Getinge’s Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices, including the Cardiosave (Hybrid and Rescue), CS300, and CS100/CS100i. The FDA recently became aware that Maquet/Datascope Cardiosave Hybrid and Rescue IABP devices may…